Downregulation of Brf1 Induces Liver Failure and Inhibits Hepatocellular Carcinoma Progression by Promoting Apoptosis

被引:0
作者
Xu, Yaping [1 ]
Yu, Chundong [3 ]
Zhang, Hongbin [4 ]
Wang, Tao [5 ]
Liu, Yujian [2 ]
Wu, Lupeng [2 ]
Zhong, Shuping [6 ]
Hong, Zaifa [2 ]
机构
[1] Fujian Prov Univ, Xiamen Med Coll, Key Lab Funct & Clin Translat Med, Xiamen, Fujian, Peoples R China
[2] Xiamen Univ, Affiliated Hosp 1, Sch Med, Dept Hepatobiliary Pancreat & Vasc Surg, Xiamen 361003, Fujian, Peoples R China
[3] Xiamen Univ, Innovat Ctr Cell Biol, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen 361102, Fujian, Peoples R China
[4] Xiamen Univ, Affiliated Hosp 1, Endoscopy Ctr, Sch Med, Xiamen 361003, Fujian, Peoples R China
[5] Xiamen Univ, Affiliated Hosp 1, Sch Med, Dept Gen Surg, Xiamen 361022, Fujian, Peoples R China
[6] Univ Southern Calif, Keck Sch Med, Dept Med, Los Angeles, CA 90033 USA
来源
JOURNAL OF CANCER | 2024年 / 15卷 / 17期
基金
中国国家自然科学基金;
关键词
Brf1; hepatocellular carcinoma; metabolism; Bcl-2; apoptosis; ALCOHOL-INDUCED DEREGULATION; III-DEPENDENT TRANSCRIPTION; CANCER CELLS; AEROBIC GLYCOLYSIS; GASTRIC-CANCER; METABOLISM; EXPRESSION; GROWTH; OVEREXPRESSION; MUTATIONS;
D O I
10.7150/jca.97277
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The occurrence and development of hepatocellular carcinoma (HCC) are closely related to abnormal apoptosis. Brf1 is highly expressed in HCC and has clinical prognostic value. Here, attenuation of Brf1-induced apoptosis was found, and the related mechanism was explored. In the study, general bioinformatics data for Brf1 were obtained from The Human Protein Atlas (HPA). Analyses of the clinical prognostic value of Brf1 in HCC were performed with the Xiantao Academic web server using R software. The basic data were obtained from the GTEx database and TCGA database. Brf1 conditional knockout mice were obtained by repeated mating of C57BL/6 Brf1LoxP/LoxP and C57BL/6 NS5A-alb-Cre-ERT2 mice and verified by genotyping. Liver function measurements, hematoxylin and eosin staining (HE), and immunohistochemistry (IHC) were performed to explore the cause of mouse death after Brf1 knockout. The Brf1 knockdown HCC cell model was generated using lentiviral vector-based shRNA transduction. Cell proliferation assays, plate colony formation assays, anchorage-independent colony formation assays and mouse subcutaneous tumor models were used to evaluate the progression of HCC. Western blot (WB) analysis, flow cytometry, and TUNEL assays were used to detect apoptosis. DNA sequencing, transcriptomics, and proteomics analyses were carried out to explore the antiapoptotic mechanism of Brf1. We found that Brf1 was highly expressed in HCC and had clinical prognostic value. Brf1 knockout led to liver failure and hepatocyte apoptosis in mice. Downregulation of Brf1 slowed HCC cell proliferation, colony growth, and mouse subcutaneous tumor growth and increased the sensitivity of HCC cells to apoptosis induced by chemotherapy drugs. The expression of Brf1 was positively related to that of the apoptosis gene Bcl-2. The sequencing, transcriptomics and proteomics analyses consistently showed that energy metabolism played an important role in Brf1 function, that protein-protein interaction was the primary mode, and that organelles such as mitochondria were the main sites. In Conclusions, downregulation of Brf1 inhibits HCC development by inducing apoptosis. Energy metabolism plays an important role in Brf1 function. These results provide a scientific basis for combating HCC.
引用
收藏
页码:5577 / 5593
页数:17
相关论文
共 52 条
  • [51] STIM1 is a metabolic checkpoint regulating the invasion and metastasis of hepatocellular carcinoma
    Zhao, Huakan
    Yan, Guifang
    Zheng, Lu
    Zhou, Yu
    Sheng, Halei
    Wu, Lei
    Zhang, Qi
    Lei, Juan
    Zhang, Jiangang
    Xin, Rong
    Jiang, Lu
    Zhang, Xiao
    Chen, Yu
    Wang, Jingchun
    Xu, Yanquan
    Li, Dingshan
    Li, Yongsheng
    [J]. THERANOSTICS, 2020, 10 (14): : 6483 - 6499
  • [52] The significance of Brf1 overexpression in human hepatocellular carcinoma
    Zhong, Qian
    Xi, Shaoyan
    Liang, Jianzhong
    Shi, Ganggang
    Huang, Yi
    Zhang, Yanmei
    Levy, Daniel
    Zhong, Shuping
    [J]. ONCOTARGET, 2016, 7 (05) : 6243 - 6254